Tau-PET-based biological staging of Alzheimer’s disease in vivo

被引:0
|
作者
机构
来源
Nature Aging | 2022年 / 2卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
High-affinity tau-PET was used to apply the Braak neuropathological staging system for Alzheimer’s disease in vivo. Tau-PET can be used to stage Alzheimer’s disease from presymptomatic to clinical dementia phases in people, while also providing a framework to model the natural history of Alzheimer’s disease using biomarkers.
引用
收藏
页码:471 / 472
页数:1
相关论文
共 50 条
  • [31] Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
    Joseph Therriault
    Tharick A. Pascoal
    Firoza Z. Lussier
    Cécile Tissot
    Mira Chamoun
    Gleb Bezgin
    Stijn Servaes
    Andrea L. Benedet
    Nicholas J. Ashton
    Thomas K. Karikari
    Juan Lantero-Rodriguez
    Peter Kunach
    Yi-Ting Wang
    Jaime Fernandez-Arias
    Gassan Massarweh
    Paolo Vitali
    Jean-Paul Soucy
    Paramita Saha-Chaudhuri
    Kaj Blennow
    Henrik Zetterberg
    Serge Gauthier
    Pedro Rosa-Neto
    Nature Aging, 2022, 2 : 526 - 535
  • [32] Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer's Disease
    Macedo, A. C.
    Durco, D. F. P. A.
    Tissot, C.
    Therriault, J.
    de Faria, A. O. Vilela
    Aumont, E.
    Servaes, S.
    Rahmouni, N.
    Fernandez-Arias, J.
    Wang, Y. -t.
    Lussier, F. Z.
    Bieger, A.
    Zimmer, E. R.
    Pascoal, T. A.
    Gauthier, S.
    Rosa-Neto, Pedro
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2024, 11 (02): : 414 - 421
  • [33] Biological mechanisms of resilience to tau pathology in Alzheimer's disease
    Svenningsson, Anna L.
    Bocancea, Diana I.
    Stomrud, Erik
    van Loenhoud, Anita
    Barkhof, Frederik
    Mattsson-Carlgren, Niklas
    Palmqvist, Sebastian
    Hansson, Oskar
    Ossenkoppele, Rik
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [34] In vivo PET imaging of neuroinflammation in Alzheimer's disease
    Lagarde, Julien
    Sarazin, Marie
    Bottlaender, Michel
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (05) : 847 - 867
  • [35] In vivo PET imaging of neuroinflammation in Alzheimer’s disease
    Julien Lagarde
    Marie Sarazin
    Michel Bottlaender
    Journal of Neural Transmission, 2018, 125 : 847 - 867
  • [36] In vivo tau PET imaging using [11C]PBB3 in Alzheimer's disease and non-Alzheimer's disease tauopathies
    Suhara, Tetsuya
    Shimada, Hitoshi
    Shinotoh, Hitoshi
    Hirano, Shigeki
    Eguchi, Yoko
    Takahata, Keisuke
    Kimura, Yasuyuki
    Yamada, Makiko
    Ito, Hiroshi
    Higuchi, Makoto
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [37] Alzheimer's Disease Classification by Combining Tau PET Imaging and Genomics
    Yang, Fan
    Song, TzuAn
    Dutta, Joyita
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [38] Tau-PET imaging as a molecular modality for Alzheimer's disease
    Ayubcha, Cyrus
    Rigney, Grant
    Borja, Austin J.
    Werner, Thomas
    Alavi, Abass
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 11 (05): : 374 - 386
  • [39] Insights into the progression of genetic Alzheimer's disease from tau PET
    Nordberg, Agneta
    LANCET NEUROLOGY, 2024, 23 (05): : 453 - 454
  • [40] Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
    Konstantinos Chiotis
    Laure Saint-Aubert
    Irina Savitcheva
    Vesna Jelic
    Pia Andersen
    My Jonasson
    Jonas Eriksson
    Mark Lubberink
    Ove Almkvist
    Anders Wall
    Gunnar Antoni
    Agneta Nordberg
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1686 - 1699